Search research articles
Contact Us
Filters
Showing results (81-90 of 118) with videos related to
Page
of 12
Sort By:
The Journal of Clinical Psychiatry
|
July 9, 2014
Double-blind, placebo-controlled study of the efficacy of reboxetine and citalopram as adjuncts to atypical antipsychotics for negative symptoms of schizophrenia
Judith Usall, Raquel López-Carrilero, Raquel Iniesta, et al.
The International Journal of Neuropsychopharmacology
|
August 21, 2023
Association of Prolactin, Oxytocin, and Homocysteine With the Clinical and Cognitive Features of a First Episode of Psychosis Over a 1-Year Follow-Up
Maria Hidalgo-Figueroa, Alejandro Salazar, Cristina Romero-López-Alberca, et al.
Journal of Clinical Medicine
|
April 12, 2022
Emotional Processing Profile in Patients with First Episode Schizophrenia: The Influence of Neurocognition
Verónica Romero-Ferreiro, Lorena García-Fernández, Ana Isabel Aparicio, et al.
Health & Place
|
March 21, 2021
How does neighbourhood socio-economic status affect the interrelationships between functioning dimensions in first episode of psychosis? A network analysis approach
Ana Izquierdo, María Cabello, Itziar Leal, et al.
Spanish Journal of Psychiatry and Mental Health
|
April 12, 2026
Sex and substance use in first episode psychosis: Impact on clinical symptoms, psychosocial functioning and cognitive performance
Gemma Safont, Marina Garriga, Silvia Amoretti, et al.
Frontiers in Endocrinology
|
December 22, 2022
The effect of early life events on glucose levels in first-episode psychosis
Clemente Garcia-Rizo, Bibiana Cabrera, Miquel Bioque, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
April 9, 2017
Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients
Sergi Mas, Patricia Gassó, Mercé Torra, et al.
Revista De Psiquiatria Y Salud Mental
|
December 3, 2014
Pharmacogenetic study of second-generation antipsychotic long-term treatment metabolic side effects (the SLiM Study): rationale, objectives, design and sample description
Laura Pina-Camacho, Covadonga M Díaz-Caneja, Pilar A Saiz, et al.
Schizophrenia Bulletin
|
January 10, 2020
Elevated Extracellular Free-Water in a Multicentric First-Episode Psychosis Sample, Decrease During the First 2 Years of Illness
Daniel Bergé, Anna Mané, Tyler A Lesh, et al.
Schizophrenia Research
|
March 21, 2024
Inflammatory blood cells and ratios at remission for psychosis relapse prediction: A three-year follow-up of a cohort of first episodes of schizophrenia
Vicent Llorca-Bofí, Santiago Madero, Silvia Amoretti, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 118) with videos related to
Sort By:
Page
of 12
The Journal of Clinical Psychiatry
|
July 9, 2014
Double-blind, placebo-controlled study of the efficacy of reboxetine and citalopram as adjuncts to atypical antipsychotics for negative symptoms of schizophrenia
Judith Usall, Raquel López-Carrilero, Raquel Iniesta, et al.
The International Journal of Neuropsychopharmacology
|
August 21, 2023
Association of Prolactin, Oxytocin, and Homocysteine With the Clinical and Cognitive Features of a First Episode of Psychosis Over a 1-Year Follow-Up
Maria Hidalgo-Figueroa, Alejandro Salazar, Cristina Romero-López-Alberca, et al.
Journal of Clinical Medicine
|
April 12, 2022
Emotional Processing Profile in Patients with First Episode Schizophrenia: The Influence of Neurocognition
Verónica Romero-Ferreiro, Lorena García-Fernández, Ana Isabel Aparicio, et al.
Health & Place
|
March 21, 2021
How does neighbourhood socio-economic status affect the interrelationships between functioning dimensions in first episode of psychosis? A network analysis approach
Ana Izquierdo, María Cabello, Itziar Leal, et al.
Spanish Journal of Psychiatry and Mental Health
|
April 12, 2026
Sex and substance use in first episode psychosis: Impact on clinical symptoms, psychosocial functioning and cognitive performance
Gemma Safont, Marina Garriga, Silvia Amoretti, et al.
Frontiers in Endocrinology
|
December 22, 2022
The effect of early life events on glucose levels in first-episode psychosis
Clemente Garcia-Rizo, Bibiana Cabrera, Miquel Bioque, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
April 9, 2017
Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients
Sergi Mas, Patricia Gassó, Mercé Torra, et al.
Revista De Psiquiatria Y Salud Mental
|
December 3, 2014
Pharmacogenetic study of second-generation antipsychotic long-term treatment metabolic side effects (the SLiM Study): rationale, objectives, design and sample description
Laura Pina-Camacho, Covadonga M Díaz-Caneja, Pilar A Saiz, et al.
Schizophrenia Bulletin
|
January 10, 2020
Elevated Extracellular Free-Water in a Multicentric First-Episode Psychosis Sample, Decrease During the First 2 Years of Illness
Daniel Bergé, Anna Mané, Tyler A Lesh, et al.
Schizophrenia Research
|
March 21, 2024
Inflammatory blood cells and ratios at remission for psychosis relapse prediction: A three-year follow-up of a cohort of first episodes of schizophrenia
Vicent Llorca-Bofí, Santiago Madero, Silvia Amoretti, et al.
Page
of 12